CDR2 and paraneoplastic neurologic syndrome: Antibodies in the Ia group are attributed to the majority of paraneoplastic syndromes (PNS) with anti-Hu and anti-Yo as the most common, accounting for up to ~50% of all PNS antibodies (5).